Novo Holdings A/S - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 47 filers reported holding SPERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$567,371
-16.6%
468,9020.0%0.04%
-20.8%
Q2 2023$679,9080.0%468,9020.0%0.05%
+17.8%
Q1 2023$679,908
-16.2%
468,9020.0%0.04%
-11.8%
Q4 2022$811,200
-13.5%
468,9020.0%0.05%
+13.3%
Q3 2022$938,000
+170.3%
468,9020.0%0.04%
+164.7%
Q2 2022$347,000
-91.5%
468,9020.0%0.02%
-92.1%
Q1 2022$4,079,000
-45.7%
468,9020.0%0.22%
-39.4%
Q4 2021$7,507,000
-13.0%
468,9020.0%0.36%
-20.4%
Q3 2021$8,632,000
+31.9%
468,9020.0%0.45%
+53.8%
Q2 2021$6,546,000
-5.2%
468,9020.0%0.29%
+1.8%
Q1 2021$6,902,000
-38.3%
468,902
-18.7%
0.28%
-40.5%
Q4 2020$11,182,000
+7.6%
576,702
-38.1%
0.48%
-7.2%
Q3 2020$10,391,000
-17.5%
931,0990.0%0.52%
-36.5%
Q2 2020$12,598,000
+67.5%
931,0990.0%0.81%
+62.0%
Q1 2020$7,523,000
-15.9%
931,0990.0%0.50%
-12.8%
Q4 2019$8,948,000
+81.2%
931,099
+99.8%
0.58%
-31.9%
Q3 2019$4,939,000
-7.9%
465,9830.0%0.85%
+12.6%
Q2 2019$5,363,000465,9830.75%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders